BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dawson-Rose C, Draughon JE, Zepf R, Cuca YP, Huang E, Freeborn K, Lum PJ. Prevalence of Substance Use in an HIV Primary Care Safety Net Clinic: A Call for Screening. J Assoc Nurses AIDS Care 2017;28:238-49. [PMID: 26763795 DOI: 10.1016/j.jana.2015.12.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Fuster-RuizdeApodaca MJ, Castro-Granell V, Garin N, Laguía A, Jaén Á, Iniesta C, Cenoz S, Galindo MJ. Prevalence and patterns of illicit drug use in people living with HIV in Spain: A cross-sectional study. PLoS One 2019;14:e0211252. [PMID: 31206550 DOI: 10.1371/journal.pone.0211252] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Pocuca N, Young JW, MacQueen DA, Letendre S, Heaton RK, Geyer MA, Perry W, Grant I, Minassian A; Translational Methamphetamine AIDS Research Center (TMARC). Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependence. Drug Alcohol Depend 2020;215:108245. [PMID: 32871507 DOI: 10.1016/j.drugalcdep.2020.108245] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Reid R, Dale SK. Moderating effects of social support on the relationship between substance use disorders and HIV viral load and medication adherence among Black women living with HIV in the United States. AIDS Care 2021;:1-10. [PMID: 34783618 DOI: 10.1080/09540121.2021.2001415] [Reference Citation Analysis]
4 Stevens ER, Nucifora KA, Irvine MK, Penrose K, Robertson M, Kulkarni S, Robbins R, Abraham B, Nash D, Braithwaite RS. Cost-effectiveness of HIV care coordination scale-up among persons at high risk for sub-optimal HIV care outcomes. PLoS One 2019;14:e0215965. [PMID: 31022280 DOI: 10.1371/journal.pone.0215965] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Pereira-Morales AJ, Acero Torres D, Moreno Zapata M, Moreno Sierra P, Astaiza Hurtado J. Design and Development of a Risk Classification Instrument for Virological Failure in HIV, Using Psychosocial Determinants of Health: Preliminary Evidence from a South American Country. AIDS Behav 2021;25:623-33. [PMID: 32889660 DOI: 10.1007/s10461-020-03025-7] [Reference Citation Analysis]
6 Empson S, Cuca YP, Cocohoba J, Dawson-Rose C, Davis K, Machtinger EL. Seeking Safety Group Therapy for Co-Occurring Substance Use Disorder and PTSD among Transgender Women Living with HIV: A Pilot Study. J Psychoactive Drugs 2017;49:344-51. [PMID: 28524758 DOI: 10.1080/02791072.2017.1320733] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
7 Langan K, Wall M, Potts W, Himelhoch S. Prevalence and potential predictors of gambling disorder among people living with HIV. AIDS Care 2019;31:421-6. [PMID: 30019914 DOI: 10.1080/09540121.2018.1499858] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
8 Liu Y, Richards VL, Gebru NM, Spencer EC, Cook RL. Associations amongst form of cocaine used (powder vs crack vs both) and HIV-related outcomes. Addict Behav Rep 2021;14:100374. [PMID: 34938835 DOI: 10.1016/j.abrep.2021.100374] [Reference Citation Analysis]
9 Schafer KR, Tanner AE, Mann-Jackson L, Alonzo J, Song EY, Rhodes SD. Stigma, Social Support, and Substance Use in Diverse Men Who Have Sex With Men and Transgender Women Living with HIV in the US Southeast. South Med J 2022;115:26-32. [PMID: 34964058 DOI: 10.14423/SMJ.0000000000001345] [Reference Citation Analysis]